Cargando…

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer

Limited data exist regarding the associations between TROP-2 protein expression, clinical–pathological characteristics, and outcome in triple-negative breast cancer (TNBC). TROP-2 expression was determined for patients diagnosed with TNBC between 2000 and 2017 by immunohistochemistry (IHC) (ab227689...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izci, Hava, Punie, Kevin, Waumans, Lise, Laenen, Annouschka, Wildiers, Hans, Verdoodt, Freija, Desmedt, Christine, Ardui, Jan, Smeets, Ann, Han, Sileny N., Nevelsteen, Ines, Neven, Patrick, Floris, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797547/ https://www.ncbi.nlm.nih.gov/pubmed/36577919 http://dx.doi.org/10.1038/s41598-022-27093-y

Ejemplares similares

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Cause of death for patients with breast cancer: discordance between death certificates and medical files, and impact on survival estimates
por: Izci, Hava, et al.
Publicado: (2021)

Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022)

Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer
por: Geers, Joachim, et al.
Publicado: (2018)

Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies
por: Clement, Céline, et al.
Publicado: (2022)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data
por: Izci, Hava, et al.
Publicado: (2023)

Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty
por: Bailur, Jithendra Kini, et al.
Publicado: (2017)

Biological ageing and frailty markers in breast cancer patients
por: Brouwers, Barbara, et al.
Publicado: (2015)

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
por: Dalmasso, Bruna, et al.
Publicado: (2018)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype
por: Brouckaert, Olivier, et al.
Publicado: (2015)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape
por: Adams, E., et al.
Publicado: (2021)

Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines
por: Dullens, Boudewijn, et al.
Publicado: (2020)

Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study
por: Wu, Qi, et al.
Publicado: (2022)

Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?
por: Van Baelen, Karen, et al.
Publicado: (2023)

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer
por: Cardillo, Thomas M., et al.
Publicado: (2020)

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
por: Jeon, Yeonjin, et al.
Publicado: (2022)

Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
por: Hatse, Sigrid, et al.
Publicado: (2014)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
por: Bravaccini, Sara, et al.
Publicado: (2021)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
por: Liu, Donglin, et al.
Publicado: (2014)

Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study
por: Verdoodt, Freija, et al.
Publicado: (2018)

The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
por: Macq, Gilles, et al.
Publicado: (2023)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Liu, Huicheng, et al.
Publicado: (2021)

The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer
por: Nevens, Daan, et al.
Publicado: (2017)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
por: Van der Vorst, Aline, et al.
Publicado: (2022)

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris
por: Slembrouck, Laurence, et al.
Publicado: (2019)

Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer
por: Smeets, Ann, et al.
Publicado: (2013)

Socio-Economic Position, Cancer Incidence and Stage at Diagnosis: A Nationwide Cohort Study in Belgium
por: Rosskamp, Michael, et al.
Publicado: (2021)

Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer
por: Berben, Lieze, et al.
Publicado: (2021)

ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
por: Punie, K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fancsjq1mmejcse6agfhijrp79